Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1.

Area of Science:

• Endocrinology
• Surgical Oncology

Background:

• Multiple endocrine neoplasia type 1 (MEN1) with hyperparathyroidism often requires multiple surgeries due to complex gland issues.
• Management challenges include inadequate initial surgery, supernumerary/ectopic glands, gland regrowth, and autograft hyperfunction.

Purpose of the Study:

• To evaluate the safety and success of reoperative parathyroidectomy in MEN1 patients.
• To assess long-term outcomes and recurrence rates of hyperparathyroidism.

Main Methods:

• Retrospective chart review and follow-up interviews of 75 patients undergoing 94 reoperative parathyroidectomies (neck reexplorations, autograft removals, sternotomies) between 1975-2000.
• Success defined as normocalcemia for >6 months post-surgery.

Main Results:

• Reoperative surgery (excluding autograft removal) achieved success in 91% of patients.
• Autograft removal success rate was 58%.
• 64% of patients remained hypercalcemia-free at a median 59-month follow-up; median time to recurrence was 125 months. Complication rate was 12%.

Conclusions:

• Reoperative parathyroidectomy is a safe and successful procedure for the majority of MEN1 patients with hyperparathyroidism.
• Recurrent hyperparathyroidism is probable beyond 10 years, indicating the need for long-term monitoring.
• The number of glands addressed during reoperation did not correlate with successful outcomes.